Evaluating and Accounting for Body Weight and Obesity / Adjusting for Body Weight
In this episode, host Dr. Christopher O'Connor is joined by Drs. Carine Hamo, Ankeet Bhatt, Joan Lindenfeld, and Martin Cowie to discuss the importance of evaluating and accounting for body weight and...
1 Heinä 28min
Derisking Phase II Clinical Trials in HF
In this episode, host Christopher O'Connor sits down with Scott D. Solomon, Ellis Unger, Janet Wittes, Michael Felker, Ben Saville, Douglas Mann, and Fady Malik to discuss how to design Phase II clini...
10 Kesä 32min
Class Effect considerations in devices
In this episode, Host Dr. Christopher O'Connor and his guests, Dr, Joann Lindenfeld, Dr. Mitchell Psotka, Dr. Minnow Walsh and Dr. William Abraham, discuss class effect considerations in devices.
20 Touko 17min
Crossover designs and event driven trials in devices
In this episode, host Christopher O’Connor and his colleagues discuss device trials and how they differ from drug trials. The conversation focuses on how device trials can be improved and how to advan...
29 Huhti 28min
Best Practices for Site-Based Research (Part 3)
Host Christopher O’Connor, MD is joined by Jana Svetlichnaya, MD; Anu Lala-Trindade, MD; and Marshall Brinkley, MD to unpack the challenges of site-based research.This episode dives into the barriers,...
8 Huhti 19min
Recurrent Events VS. Time to First Event Analysis
This episode explores two different ways of analyzing outcomes in clinical trial and longitudinal studies in cardiovascular and heart failure research.
18 Maalis 26min
The Role of Using Data from Real World Evidence to Inform Regulatory Applications
In this episode, host Dr. Christopher O'Connor sits down with Dr. Robert Califf, MD, Nicholaas Honig, JD, Dr. Maria Rosa Costanzo, and Dr. Norman Stockbridge, MD, PhD to explore the role of real-world...
25 Helmi 25min
